Alphatec Holdings, Inc. (ATEC)
Healthcare · Medical Devices · NasdaqGS
Alphatec Holdings, Inc. revenue & earnings — last 10 fiscal years
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $120.25M | $101.74M | $91.69M | $113.43M | $144.86M | $243.21M | $350.87M | $482.26M | $611.56M | $764.15M |
| Gross profit | $76.13M | $68.22M | $63.24M | $77.59M | $102.50M | $157.76M | $233.06M | $310.20M | $424.26M | $531.89M |
| Net income | $-29.93M | $-2.29M | $-28.98M | $-57.00M | $-78.99M | $-143.03M | $-151.29M | $-186.64M | $-162.12M | $-143.36M |
| Net margin | -24.9% | -2.3% | -31.6% | -50.3% | -54.5% | -58.8% | -43.1% | -38.7% | -26.5% | -18.8% |
Source: Alphatec Holdings, Inc. SEC filings (10-K). 17 years of history available in the interactive view.
Explore 17 years of Alphatec Holdings, Inc. financials — interactive
Full income statement, balance sheet and cash flow with CAGR and trend on every row, 48 quarters, valuation ratios, plain-English health checks, and Ask — our SEC-grounded research assistant.
Open the interactive view — freeOr start a 7-day free trial to track ATEC in your portfolio →
Alphatec Holdings, Inc. financial history by metric
About Alphatec Holdings, Inc.
Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. The company manufactures and sells implants, instruments, imaging equipment, and spare parts. It offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; SafeOp Neural InformatiX System that automates electromyographic, somatosensory evoked potential, and motor evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissue; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives. The company was founded in 1990 and is headquartered in Carlsbad, California.
Alphatec Holdings, Inc. — frequently asked questions
What is Alphatec Holdings, Inc.'s revenue?
Alphatec Holdings, Inc. (ATEC) reported revenue of $764.15M for fiscal year 2025, up 25.0% from the prior year, according to its SEC filings.
Is Alphatec Holdings, Inc. profitable?
No — ATEC reported a net loss of $-143.36M in fiscal 2025.
What is ATEC's P/E ratio?
Alphatec Holdings, Inc. trades at a price-to-earnings ratio of about 0.0 based on the latest data in our nightly-refreshed cache.
How fast is Alphatec Holdings, Inc. growing?
ATEC's revenue grew at roughly 39.5% per year over the last five fiscal years (compound annual growth rate), computed from SEC-filed statements.
How much debt does Alphatec Holdings, Inc. have?
As of fiscal year 2025, ATEC carried roughly $565.94M in total debt (short- plus long-term borrowings), per its filed balance sheet.
What is Alphatec Holdings, Inc.'s gross margin?
ATEC's gross margin was 69.6% in fiscal 2025 — gross profit of $531.89M on revenue of $764.15M.
What is Alphatec Holdings, Inc.'s market cap?
Alphatec Holdings, Inc. (ATEC) has a market capitalization of about $1.25B, based on the latest data in our nightly-refreshed cache.
When does Alphatec Holdings, Inc.'s fiscal year end?
ATEC's fiscal year ends in December. Its most recent annual filing covers the fiscal year ending 2025-12-31.
Where does this data come from?
All figures are computed from Alphatec Holdings, Inc.'s official SEC filings (10-K and 10-Q), covering 17 years of history, refreshed nightly. stockportfolio.pro does not provide investment advice.